Stay updated on Vicriviroc and Pembrolizumab in MSS CRC Clinical Trial

Sign up to get notified when there's something new on the Vicriviroc and Pembrolizumab in MSS CRC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Vicriviroc and Pembrolizumab in MSS CRC Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    Revision updated from v3.4.2 to v3.4.3. The update appears to concern site versioning rather than the study details.
    Difference
    0.0%
    Check dated 2026-03-12T02:21:00.000Z thumbnail image
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    No Change Detected
  4. Check
    34 days ago
    Change Detected
    Summary
    Revision: v3.4.2 has been added. The previous funding-status notice and Revision: v3.4.1 have been removed.
    Difference
    0.4%
    Check dated 2026-02-11T12:27:07.000Z thumbnail image
  5. Check
    41 days ago
    Change Detected
    Summary
    Added a government funding lapse notice. Updated the site to revision v3.4.1, replacing v3.4.0.
    Difference
    0.4%
    Check dated 2026-02-04T06:50:50.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    Glossary visibility was added and footer metadata was updated to include 'Last Update Submitted that Met QC Criteria' and 'Revision: v3.4.0', with capitalization changes in related labels.
    Difference
    0.2%
    Check dated 2026-01-28T04:49:11.000Z thumbnail image
  7. Check
    62 days ago
    Change Detected
    Summary
    Revision updated from v3.3.3 to v3.3.4. This is a minor version update with no impact on study content or functionality. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-01-14T01:36:26.000Z thumbnail image
  8. Check
    84 days ago
    Change Detected
    Summary
    Added a dedicated Locations section with regional site listings (Arizona, California, Florida, Tennessee, Texas, Alberta, and Quebec) and replaced the previous location blocks. The HHS Vulnerability Disclosure link was removed in this update.
    Difference
    0.8%
    Check dated 2025-12-23T10:37:31.000Z thumbnail image

Stay in the know with updates to Vicriviroc and Pembrolizumab in MSS CRC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Vicriviroc and Pembrolizumab in MSS CRC Clinical Trial page.